ZYUS Life Sciences Corporation Announces Closing of Sixth Tranche of…

Lane

Debt financing

Announced

21 Jul 2026

Province

Saskatchewan

Industry

Healthcare & life sciences

Status

Announced

What the filing says

ZYUS Life Sciences Corporation (the " Company ") (TSXV: ZYUS ), a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, is pleased to announce that its wholly-owned subsidiary, ZYUS Life Sciences Inc. (" ZYUS Inc. "), has closed a sixth tranche (the " Sixth Tranche ") of a secured loan financing (the " Secured Loan ") on July 21, 2026 with certain lenders (the " Lenders" ), including an insider of the Company, for gross proceeds of CAD$150,000.

Consideration

$150k

interest rate

12% (per annum)“The Secured Loan bears interest at a rate of 12% per annum, payable on maturity, is pre-payable by ZYUS Inc. at any time without penalty or premium, and will mature on November 19, 2026.”

maturity date

2026-11-19“The Secured Loan bears interest at a rate of 12% per annum, payable on maturity, is pre-payable by ZYUS Inc. at any time without penalty or premium, and will mature on November 19, 2026.”

maturity term

6 months (6 months as stated)“The Secured Loan bears interest at a rate of 12% per annum, payable on maturity, is pre-payable by ZYUS Inc. at any time without penalty or premium, and will mature six months from the effective date of the loan.”

Releases (4)

28 May 2026 — ZYUS Life Sciences Corporation Announces Closing of Second Tranche of Secured Loan Financing and Provides an Update on its Annual Filings…
17 Jun 2026 — ZYUS Life Sciences Corporation Announces Closing of Third Tranche of Secured Loan Financing
24 Jun 2026 — ZYUS Life Sciences Corporation Announces Closing of Fourth Tranche of Secured Loan Financing
21 Jul 2026 — ZYUS Life Sciences Corporation Announces Closing of Sixth Tranche of Secured Loan Financing

Source

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe

ZYUS Life Sciences Corporation Announces Closing of Sixth Tranche of Secured Loan Financing